Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial.
Saved in:
| Title: | Effects of a Technology-Assisted Integrated Diabetes Care Program on Cardiometabolic Risk Factors Among Patients With Type 2 Diabetes in the Asia-Pacific Region: The JADE Program Randomized Clinical Trial. |
|---|---|
| Authors: | Lim LL; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.; Asia Diabetes Foundation, Shatin, Hong Kong Special Administrative Region, China.; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Lau ESH; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.; Asia Diabetes Foundation, Shatin, Hong Kong Special Administrative Region, China., Fu AWC; Asia Diabetes Foundation, Shatin, Hong Kong Special Administrative Region, China., Ray S; Relief Polyclinic, Hoogly, India., Hung YJ; Tri-Service General Hospital, Taipei, Taiwan., Tan ATB; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Now with Sunway Medical Centre, Selangor, Malaysia., Chamnan P; Sanpasitthiprasong Hospital, Ubon Ratchathani, Thailand., Sheu WHH; Taichung Veterans General Hospital, Taichung, Taiwan., Chawla MS; Lina Diabetes Care Centre, Mumbai, India., Chia YC; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Chuang LM; National Taiwan University Hospital, Taipei, Taiwan., Nguyen DC; Thong Nhat Hospital, Ho Chi Minh, Vietnam., Sosale A; Diacon Hospital, Bangalore, India., Saboo BD; Dia Care-Diabetes Care and Hormone Clinic, Gujarat, India., Phadke U; Instride, Pune, India., Kesavadev J; Jothydev's Diabetes and Research Center, Kerala, India., Goh SY; Department of Endocrinology, Singapore General Hospital, Outram Road, Singapore., Gera N; Max Healthcare Institute, New Delhi, India., Huyen Vu TT; Department of Internal Medicine, Hanoi Medical University, Hanoi, Vietnam., Ma RCW; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China., Lau V; Asia Diabetes Foundation, Shatin, Hong Kong Special Administrative Region, China., Luk AOY; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.; Asia Diabetes Foundation, Shatin, Hong Kong Special Administrative Region, China.; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China., Kong APS; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China., Chan JCN; Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.; Asia Diabetes Foundation, Shatin, Hong Kong Special Administrative Region, China.; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China.; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong Special Administrative Region, China. |
| Corporate Authors: | Asia-Pacific JADE Study Group |
| Source: | JAMA network open [JAMA Netw Open] 2021 Apr 01; Vol. 4 (4), pp. e217557. Date of Electronic Publication: 2021 Apr 01. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2574-3805 |
|---|---|
| DOI: | 10.1001/jamanetworkopen.2021.7557 |
